Ombitasvir-d16
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Ombitasvir-d16 Product Information
Ombitasvir-d16 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-96690.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Ombitasvir-d16
CAT No.
CS-T-96690
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C50H51D16N7O8
Molecular Weight
910.21
Category
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Ombitasvir-d16 is supplied with detailed characterization data compliant with regulatory guideline. Ombitasvir-d16 can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
Overview
"Ombitasvir-d16 is labelled Ombitasvir (O633200), which is a pharmaceutical drug that is used in the treatment of hepatitis C virus in patients with HCV genotype 1 infection. Ombitasvir inhibits an important viral phosphoprotein, NS5A, which is involved in viral replication, assembly, and secretion."
Synonyms
Ombitasvir-d16
Application Notes
"Ombitasvir-d16 is labelled Ombitasvir (O633200), which is a pharmaceutical drug that is used in the treatment of hepatitis C virus in patients with HCV genotype 1 infection. Ombitasvir inhibits an important viral phosphoprotein, NS5A, which is involved in viral replication, assembly, and secretion."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.